A patient with Stage 4 chronic kidney disease presents with significant proteinuria, elevated serum creatinine, hyperkalemia, and metabolic acidosis. Which of the following nursing interventions is the highest priority to address the patient's immediate health risks?

C) Prepare the patient for hemodialysis to manage severe electrolyte imbalances.

A) Administer sodium polystyrene sulfonate to reduce serum potassium levels.

B) Initiate dietary protein restriction to decrease proteinuria.

C) Prepare the patient for hemodialysis to manage severe electrolyte imbalances.

D) Administer intravenous sodium bicarbonate to correct metabolic acidosis.

A patient with Stage 4 chronic kidney disease presents with significant proteinuria, elevated serum creatinine, and hyperkalemia. Given the current laboratory findings, which nursing intervention should be prioritized to address the most immediate risk to the patient's health?

B) Administer sodium polystyrene sulfonate to correct hyperkalemia.

A) Initiate dietary protein restriction to reduce proteinuria.

B) Administer sodium polystyrene sulfonate to correct hyperkalemia.

C) Increase fluid intake to enhance renal perfusion and urine output.

D) Administer intravenous sodium bicarbonate to correct metabolic acidosis.

A patient with chronic kidney disease is experiencing a sudden surge in blood pressure, worsening fluid overload, and severe electrolyte imbalances. The clinical team is considering the initiation of hemodialysis. Which factor should the nurse prioritize when determining the need for immediate dialysis initiation?

C) The potassium level of 6.5 mEq/L indicating severe hyperkalemia

A) The presence of bilateral crackles in the lung bases indicating fluid overload

B) The serum creatinine level of 5.0 mg/dL and eGFR of 15 mL/min/1.73 m²

C) The potassium level of 6.5 mEq/L indicating severe hyperkalemia

D) The pH level of 7.25 indicating metabolic acidosis

A patient presents with rapidly deteriorating renal function, severe hypertension, fluid overload, and metabolic acidosis. The clinical team is considering initiating hemodialysis. Which action should the nurse prioritize to address the patient's immediate clinical needs?

B) Initiate emergency hemodialysis to correct electrolyte imbalances and fluid overload.

A) Administer antihypertensive medications to reduce blood pressure.

B) Initiate emergency hemodialysis to correct electrolyte imbalances and fluid overload.

C) Provide supplemental oxygen and elevate the head of the bed to improve respiratory status.

D) Administer sodium bicarbonate to correct metabolic acidosis.

A patient with acute decompensated heart failure is being managed with hemodialysis, ACE inhibitors, and diuretics. Given the recent diagnostic findings of reduced ejection fraction, elevated BNP, and pulmonary congestion, which nursing action is the highest priority to prevent further complications?

A) Monitor the patient's blood pressure closely and adjust medications accordingly.

B) Administer supplemental oxygen to maintain adequate oxygenation levels.

C) Educate the patient on fluid restrictions and dietary modifications.

D) Assess and document lung sounds frequently to detect changes in pulmonary status.

A patient with acute decompensated heart failure and renal dysfunction is being managed with hemodialysis and an adjusted pharmacologic regimen. Which nursing intervention is most critical to prioritize in this scenario to ensure optimal patient outcomes?

B) Evaluate electrocardiogram (ECG) changes frequently to detect potential cardiac arrhythmias.

A) Monitor daily weights to assess fluid balance and adjust diuretic dosage accordingly.

B) Evaluate electrocardiogram (ECG) changes frequently to detect potential cardiac arrhythmias.

C) Assess neurological status regularly to identify signs of uremic encephalopathy.

D) Measure urine output hourly to monitor renal function and fluid status.

A patient undergoing hemodialysis has developed hypotensive episodes and worsening renal function with rising potassium levels. Which nursing intervention should be prioritized to address the immediate life-threatening complication?

B) Administer a calcium gluconate infusion to stabilize cardiac membranes

A) Increase the rate of fluid removal during hemodialysis to manage pulmonary congestion

B) Administer a calcium gluconate infusion to stabilize cardiac membranes

C) Initiate a low-potassium diet to manage rising potassium levels

D) Administer a diuretic to assist in fluid removal and manage blood pressure

A patient undergoing hemodialysis for acute renal failure is experiencing hypotensive episodes with blood pressure readings of 95/60 mmHg and rising potassium levels at 5.8 mEq/L. Which nursing intervention is most critical at this time to address both the hypotension and hyperkalemia?

B) Administer a bolus of intravenous normal saline and reassess the fluid removal rate to stabilize blood pressure while considering potassium-binding agents.

A) Increase the rate of fluid removal during dialysis to improve renal function and reduce serum potassium levels.

B) Administer a bolus of intravenous normal saline and reassess the fluid removal rate to stabilize blood pressure while considering potassium-binding agents.

C) Temporarily discontinue hemodialysis and administer intravenous calcium gluconate to protect the heart from the effects of hyperkalemia.

D) Continue with the prescribed fluid removal rate and administer oral sodium polystyrene sulfonate to reduce potassium levels.

A patient with severe uremia and fluctuating electrolyte levels has developed neurological symptoms and cardiovascular instability with persistent hypotension and tachycardia. Considering the urgent need for metabolic correction and stabilization, which nursing intervention should be prioritized to prevent further complications?

C) Administer calcium gluconate and initiate an insulin-glucose infusion to manage hyperkalemia and stabilize cardiac function.

A) Administer mannitol to reduce cerebral edema and prevent neurological deterioration.

B) Initiate a hypertonic saline infusion to address cerebral edema and stabilize blood pressure.

C) Administer calcium gluconate and initiate an insulin-glucose infusion to manage hyperkalemia and stabilize cardiac function.

D) Increase intravenous fluid rate to improve hypotension and support renal function.

A patient with severe uremia is experiencing neurological symptoms and cardiovascular instability, including a headache, confusion, disorientation, persistent hypotension, and tachycardia. Neuroimaging reveals mild cerebral edema, and cardiac monitoring shows frequent premature ventricular contractions due to hyperkalemia. Which nursing intervention is most critical to prioritize in managing this patient's complex condition?

C) Continuing the insulin-glucose infusion and administering calcium gluconate to address hyperkalemia and stabilize cardiac function.

A) Administering mannitol to reduce cerebral edema and alleviate neurological symptoms.

B) Initiating a high-dose diuretic therapy to manage fluid overload and reduce cerebral edema.

C) Continuing the insulin-glucose infusion and administering calcium gluconate to address hyperkalemia and stabilize cardiac function.

D) Increasing intravenous fluid administration to improve hypotension and enhance renal perfusion.

glomerulonephritis - Nursing Case Study

Pathophysiology

• Primary mechanism: Immune complex deposition leads to inflammation and thickening of the glomerular basement membrane, impairing filtration by reducing permeability and surface area, resulting in proteinuria and hematuria.

• Secondary mechanism: Activation of the complement system enhances inflammation and attracts leukocytes, causing further glomerular injury and potential progression to nephron loss.

• Key complication: Persistent glomerular damage can culminate in renal scarring (glomerulosclerosis), which significantly decreases renal function and may lead to chronic kidney disease or end-stage renal failure, necessitating dialysis or transplantation.

Patient Profile

Demographics:

42-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Chronic Kidney Disease Stage 3

• Current medications: Lisinopril, Metformin, Furosemide, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe swelling and fatigue

• Key symptoms: Hematuria, edema in lower extremities, shortness of breath, oliguria

• Vital signs: Blood pressure 190/120 mmHg, heart rate 110 bpm, respiratory rate 28 breaths/min, temperature 38.2°C, oxygen saturation 88% on room air

Section 1

New Diagnostic Results:

Following the initial assessment, the medical team prioritized further diagnostic testing to understand the extent of the patient's renal impairment and associated complications. Laboratory results revealed significant proteinuria with a urine protein-to-creatinine ratio of 4.5 g/g, indicating substantial nephron damage. Serum creatinine levels were elevated at 4.2 mg/dL, reflecting a marked decline in renal function compared to baseline. Estimated glomerular filtration rate (eGFR) had dropped to 20 mL/min/1.73 m², confirming the progression from Stage 3 to Stage 4 chronic kidney disease. Additionally, the urinalysis showed marked hematuria with numerous dysmorphic red blood cells, suggestive of glomerular origin, and mild leukocyturia without signs of infection.

Serological tests returned positive for anti-streptolysin O (ASO) titers, indicating a likely post-infectious glomerulonephritis, possibly secondary to a recent streptococcal infection. Complement levels were notably decreased, with C3 at 45 mg/dL (normal range: 90-180 mg/dL), consistent with complement consumption due to immune complex-mediated glomerular inflammation. The patient's electrolyte panel displayed hyperkalemia with a potassium level of 6.0 mEq/L, posing a risk for cardiac arrhythmias, and metabolic acidosis with a bicarbonate level of 16 mEq/L, necessitating immediate correction.

These findings necessitate a reevaluation of the current treatment plan, with consideration for potential initiation of renal replacement therapy. The medical team must also address the critical electrolyte imbalances and manage hypertension aggressively to prevent further renal and cardiovascular complications. This complex clinical picture requires astute clinical reasoning to optimize therapeutic interventions and mitigate the risk of progressing to end-stage renal disease.

Section 2

Change in Patient Status:

Despite the initial interventions aimed at stabilizing the patient's condition, the clinical team observed a concerning change in the patient's status. Vital signs indicated a sudden surge in blood pressure to 190/110 mmHg, exacerbating the risk for acute cardiovascular events such as heart failure or stroke. The patient also reported new-onset dyspnea and orthopnea, suggesting possible fluid overload secondary to impaired renal function and hypertension. On physical examination, bilateral crackles were auscultated in the lung bases, and there was evidence of 3+ pitting edema extending to the knees, confirming worsening fluid retention.

Laboratory assessments revealed further deterioration in renal function, with serum creatinine climbing to 5.0 mg/dL and eGFR dropping to 15 mL/min/1.73 m². The patient's electrolyte disturbances persisted, with potassium levels rising to 6.5 mEq/L, intensifying the risk for life-threatening arrhythmias. Despite bicarbonate supplementation, metabolic acidosis persisted, with arterial blood gas analysis showing a pH of 7.25 and bicarbonate level remaining at 15 mEq/L. This acidosis indicated an insufficient response to medical management, necessitating a reassessment of the treatment approach.

Given these developments, the clinical team faced the critical decision of whether to initiate hemodialysis to manage the severe electrolyte imbalances and fluid overload. This decision required careful consideration of the patient's overall cardiovascular stability and the potential risks associated with dialysis initiation. The evolving complexity of the case mandated advanced clinical judgment to prioritize interventions that would stabilize the patient's condition while preventing further renal and systemic complications, paving the way for the next phase of intensive management.

Section 3

New Diagnostic Results:

In light of the patient's deteriorating condition, the clinical team expedited further diagnostic evaluations to elucidate the underlying causes of the worsening clinical picture. A comprehensive echocardiogram was performed, revealing a reduced ejection fraction of 35%, consistent with systolic heart failure likely exacerbated by the acute hypertensive crisis and fluid overload. This finding illuminated the precarious balance between cardiac and renal dysfunction, complicating management strategies. Additionally, a chest X-ray confirmed significant pulmonary congestion, correlating with the auscultated crackles and the patient's respiratory symptoms.

Concurrently, a repeat set of laboratory investigations highlighted an alarming trend. The patient's troponin levels were mildly elevated at 0.12 ng/mL, raising concerns for possible myocardial injury secondary to the hypertensive emergency and metabolic imbalances. Meanwhile, the patient's B-type natriuretic peptide (BNP) level surged to 1200 pg/mL, corroborating the diagnosis of acute decompensated heart failure. These diagnostic results underscored the intricate interplay between the renal and cardiovascular systems in this patient, necessitating a nuanced therapeutic approach to simultaneously address both organ systems' dysfunctions.

The culmination of these diagnostic insights prompted the interdisciplinary team to refine the treatment plan. Hemodialysis was initiated with caution, focusing on gradual fluid removal to mitigate cardiovascular strain while correcting electrolyte and acid-base disturbances. The team also adjusted the pharmacologic regimen, incorporating an ACE inhibitor and diuretics to optimize cardiac function and control blood pressure. This phase of management required meticulous monitoring and coordination to prevent precipitous changes in hemodynamic status, guiding the patient's path toward stabilization and recovery.

Section 4

Response to Interventions:

Following the initiation of hemodialysis and the adjusted pharmacologic regimen, the patient's clinical status was closely monitored to evaluate the effectiveness of the interventions. Initially, there was a modest improvement in respiratory function, with the patient experiencing a slight reduction in dyspnea and improved oxygen saturation, now consistently at 92% on supplemental oxygen. The careful fluid removal strategy began to alleviate pulmonary congestion, as evidenced by diminishing crackles upon auscultation. However, as the team continued with hemodialysis, the patient developed hypotensive episodes, with blood pressure readings dropping to 95/60 mmHg, prompting a reassessment of the fluid removal rate and necessitating the temporary cessation of dialysis.

Concurrently, the patient's renal function continued to decline, as indicated by rising serum creatinine levels, now at 3.5 mg/dL, and worsening uremia, with BUN levels climbing to 85 mg/dL. Despite the tailored interventions, these changes pointed toward a complex interplay between ongoing renal impairment and the cardiovascular compromise, revealing the challenging tightrope the team faced in balancing fluid management with hemodynamic stability. Furthermore, the patient's potassium level, which had initially normalized, began to rise again, reaching 5.8 mEq/L, necessitating urgent attention to prevent arrhythmogenic complications. This development called for an urgent interdisciplinary meeting to reassess the management plan, emphasizing the need for dynamic adjustments in therapeutic strategies to address the multifaceted nature of the patient's condition.

Section 5

New Complications

As the interdisciplinary team reconvened to address the evolving complications, it became apparent that the patient's condition was entering a precarious phase. Despite the initial stabilization of respiratory function, the patient began exhibiting signs of neurological involvement, likely secondary to the severe uremia and fluctuating electrolyte levels. The patient reported experiencing a persistent headache, coupled with episodes of confusion and disorientation. Neurological assessment revealed a reduced level of consciousness with a Glasgow Coma Scale (GCS) score now at 13, indicating moderate impairment. This change prompted urgent neuroimaging, which ruled out intracranial bleeding but suggested mild cerebral edema, a concerning development that necessitated immediate intervention.

In parallel, the patient's cardiovascular status exhibited further instability. The hypotensive episodes persisted, and the patient developed tachycardia, with heart rates consistently in the range of 110-120 beats per minute. These hemodynamic alterations raised suspicions of autonomic dysregulation, potentially exacerbated by the underlying systemic inflammatory response. Continuous cardiac monitoring revealed occasional premature ventricular contractions, underscoring the critical need to address the rising hyperkalemia more aggressively to prevent further arrhythmias. The team initiated calcium gluconate to stabilize cardiac membranes and commenced an insulin-glucose infusion to drive potassium back into cells.

These new complications necessitated a recalibration of the treatment approach, focusing on a delicate balance between aggressive metabolic correction and supportive care. The evolving situation required comprehensive discussions with the nephrology, cardiology, and neurology teams to formulate a cohesive, interdisciplinary plan that could dynamically respond to this cascade of interrelated complications. As the team worked to stabilize the patient, they remained vigilant, recognizing that each intervention carried potential risks and benefits that had to be carefully weighed against the backdrop of the patient's fragile state.